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Abstract  MR  imaging  is  currently  regarded  as  a  pivotal  technique  for  the  assessment  of  a  vari-
ety of  musculoskeletal  conditions.  Diffusion-weighted  MR  imaging  (DWI)  is  a  relatively  recent
sequence that  provides  information  on  the  degree  of  cellularity  of  lesions.  Apparent  diffu-
sion coefﬁcient  (ADC)  value  provides  information  on  the  movement  of  water  molecules  outside
the cells.  The  literature  contains  many  studies  that  have  evaluated  the  role  of  DWI  in  mus-
culoskeletal  diseases.  However,  to  date  they  yielded  conﬂicting  results  on  the  use  and  the
diagnostic capabilities  of  DWI  in  the  area  of  musculoskeletal  diseases.  However,  many  of  them
have showed  that  DWI  is  a  useful  technique  for  the  evaluation  of  the  extent  of  the  disease  in  a
subset of  musculoskeletal  cancers.  In  terms  of  tissue  characterization,  DWI  may  be  an  adjunct
to the  more  conventional  MR  imaging  techniques  but  should  be  interpreted  along  with  the  sig-
nal of  the  lesion  as  observed  on  conventional  sequences,  especially  in  musculoskeletal  cancers.
Regarding the  monitoring  of  response  to  therapy  in  cancer  or  inﬂammatory  disease,  the  use  of
ADC value  may  represent  a  more  reliable  additional  tool  but  must  be  compared  to  the  initial
ADC value  of  the  lesions  along  with  the  knowledge  of  the  actual  therapy.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.MR  imaging  is  currently  regarded  as  a  pivotal  technique  for  the  assessment  of  a
variety  of  musculoskeletal  conditions.  Alongside  conventional  morphological  MR  imaging
(i.e.,  T1-weighted,  T2-weighted,  STIR  and  T1-weighted  after  gadolinium  administration),
‘‘functional’’  MR  imaging  has  been  developed  to  improve  the  diagnostic  capabilities  of  MR
imaging.  Diffusion-weighted  imaging  (DWI)  is  a  relatively  recent  MR  imaging  sequence  that
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rovides  information  about  the  degree  of  cellularity  of
esions.  The  apparent  diffusion  coefﬁcient  (ADC)  value
rovides  information  about  movement  of  intra-  and  extra-
ellular  water.
The  literature  contains  many  studies  that  have  evalu-
ted  the  role  of  DWI  in  musculoskeletal  diseases.  However,
o  date  they  yielded  conﬂicting  results  on  the  use  and  the
iagnostic  capabilities  of  DWI  in  the  area  of  musculoskeletal
iseases.
The  aim  of  this  review  was  to  attempt  to  clarify  the  place
f  DWI  in  musculoskeletal  imaging.
rinciple of diffusion
he  basic  principle  behind  DWI  is  the  stochastic  Brown-
an  motion  or  speciﬁc  diffusion  of  extra-cellular  water
olecules  within  tissues  [1].  Diffusivity  is  represented  by  a
uantitative  variable,  the  ADC,  which  is  the  ﬁrst  line  assess-
ent  method  for  DWI  data.  Diffusion  therefore  indirectlyeﬂects  the  histology  of  tissues  (cellularity,  but  also  ﬁbrosis
nd  hemoglobin  degradation  products)  (Fig.  1).
In  the  case  of  highly  cellular  tissue  (weak  diffusion),  the
erm  restriction  of  diffusion  is  used.  This  is  represented  by
igure 1. Low cellularity in healthy tissue and therefore straight-
orward diffusion of water into the interstitial space. Conversely
ovement of water molecules into the interstitial is reduced in
issue with hyper-cellularity.
igure 2. Illustration of image depending on the b value chosen with a 
a) which falls progressively and a tissue hyper-intensity on diffusion-w
ersists when the b value increases (arrows).
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 large  hyper-intensity  on  diffusion-weighted  images,  with
 low  ADC.  In  paucicellular  tissue  (high  diffusion),  the  term
ncreased  diffusion  is  used  and  is  represented  by  a  weak
yper-intensity  on  diffusion-weighted  MR  image  and  a  high
DC.
Malignant  tissues  are  generally  more  cellular  than  benign
issues  and  extra-cellular  water  molecule  diffusion  in  these
issues  is  therefore  lower  because  of  the  presence  of  many
acromolecules  and  cell  membranes  with  anarchic  cellular
roliferation  [1].
echnique
WI  is  obtained  by  spin  out  of  phase  using  a  diffusion  gradi-
nt  (b)  with  in  phase  using  a  second  gradient.  When  diffusion
s  high  the  return  to  phase  is  incomplete:  spins  are  out  of
hase,  move  and  no  longer  make  use  of  the  back  in  phase
radient.  The  signal  is  therefore  reduced  on  DWI  and  the
DC  is  raised.  In  lesions  with  high  cellularity,  diffusion  is
estricted:  the  spins  are  out  of  phase  and  poorly  mobile  and
eturn  to  phase.  The  signal  is  maximal  in  diffusion-weighted
maging  (in  the  case  of  cytotoxic  oxygen)  and  the  ADC  is
ow.
Several  b  factors  (b  values)  may  be  chosen.  The  use
f  b  factors  varies  but  is  generally  high.  If  b  =  0 or  low,
 T2-weighted  image  is  obtained  without  a  true  diffusion-
eighted  image.  Conversely  if  the  b  value  is  high  (for
xample  b  =  1000)  a  genuine  diffusion-weighted  image  is
btained  beyond  the  T2  and  perfusion  image,  generally  with
oorer  spatial  resolution  and  a  poorer  signal  to  noise  ratio
SNR)  (Fig.  2).  Diffusion-weighted  MR  images  must  therefore
e  assessed  visually,  comparing  the  images  obtained  with  a
ow  b  value  (T2-weighting)  to  those  obtained  with  a  high  b
alue.  The  difference  in  signal  between  these  two  images
s  related  to  water  diffusion.  This  type  of  analysis  is  highly
ubjective  and  poorly  reproducible.liquid hyper-intensity on diffusion-weighted imaging of the bladder
eighted imaging of the tumor (b): in a 25-year-old patient which
ADC  analysis  is  the  ﬁrst  line  assessment  method  for  dif-
usion  data.  The  ADC  is  visible  in  grey  shades  or  in  color  (via
 look  up  table)  on  the  ADC  map  of  a  lesion  and  is  expressed
uantitatively  as  mm2·s−1.  A  minimum,  mean  or  maximum
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Figure 4. Seventy-nine-year-old woman with hip prosthesis. Mag-
netic susceptibility artifact on DWI is due to the prosthesis.
t
d
bDiffusion-weighted  MR  imaging  in  musculoskeletal  diseases:
ADC  can  be  calculated  but  it  is  usually  the  mean  ADC  that
is  used  despite  the  fact  that  the  minimum  ADC  value  better
correlates  with  histological  ﬁndings  [2—4]  (Fig.  3).
Alongside  the  b  factor  in  DWI,  there  are  several  types
of  sequences  used,  each  of  them  having  its  own  advantages
and  limitations  [3].
Five  types  of  DWI  sequence  can  be  distinguished:
• spin  echo  DWI:  this  is  a  simple  spin  echo  sequence  which
has  the  advantage  of  being  a  homogeneous  sequence  with
a  high  SNR  but  with  the  detriment  of  a  long  acquisition
time;
• SS-EPI  (Steady-State  Echo  planar):  this  is  a  fast  spin  echo
sequence  with  planar  echo  (impulse  couple  of  90  and
then  180  degrees)  on  T2-weighting.  The  SNR  and  image
acquisition  time  are  satisfactory  although  large  magnetic
susceptibility  artefacts  may  occur.  This  is  the  imaging
sequence  which  is  most  often  used,  in  our  experience
(Fig.  4);
• MS-EPI  (MultiShot  Echo  planar)  is  also  an  echo  planar  and  is
less  sensitive  to  artefacts  and  distortion  effects,  increas-
ing  spatial  resolution  but  at  the  penalty  of  a  longer  image
acquisition  time;
• SS-FSE  (Single  Shot  Fast  Spin  Echo)  (rare  or  haste)  is  a
fast  spin  echo  ‘‘single  shot’’  T2-weighted  MR  sequence.
The  acquisition  time  and  spatial  resolution  are  identical
although  it  has  the  advantage  of  multiple  images  being
acquired;
• SS-FP  DWI  (Steady-State  Free  Precession):  this  is  an  echo
gradient  imaging  sequence  with  fat  saturation.  The  b  val-
ues  are  low  enabling  a  qualitative  analysis.
One  should  note  that  usually  musculoskeletal  lesions
are  assessed  using  an  SS-EPI  with  a  high  b  value  (over
600).The  ‘‘T2  shine  through’’  should  be  understood.  This  is,
conventionally,  an  intense  diffusion-weighted  image  with-
out  a  reduction  in  the  ADC  (no  restriction)  because  of
a
w
F
Figure 3. Twenty-ﬁve-year-old male. DWI shows moderate hypersigna
restriction of diffusion and a high ADC (black arrow in ﬁgure a) compare
DWI with restricted diffusion and a low ADC (white arrows in ﬁgure b).he  presence  of  large  amounts  of  ﬂuid  in  the  lesion.  Any
iffusion-weighted  imaging  must,  therefore,  be  interpreted
y  a  comparison  against  conventional  T1-  and  T2-weighted
natomical  images,  possibly  using  gadolinium  enhanced  T1-
eighted  imaging  [4]  (Fig.  5).
All  possible  interpretations  of  DWI  are  summarized  inig.  6  [3].
l of the bladder with a b value of 600 (white arrow in a) with no
d to a soft tissue tumor (in a) also with a hyper-intensity on b600
330  
Figure 5. Forty-three-year-old male with left hydrocele. DWI
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ihows T2 ‘‘shine through’’ effect. Note the hyper-intensity on b600
2-weighted images with no reduction in the ADC.
linical applications
ncology
rimary bone tumors
arly  studies  dealing  with  DWI  were  intended  to  charac-
erize  bone  tumors  and  attempted  to  distinguish  between
alignant  and  benign  tumors  [3].
Basically,  it  is  widely  accepted  that,  in  malignant  aggres-
ive  tumors  the  ADC  is  low,  whereas  it  is  high  in  benign
umors.  Things  are  more  complicated  than  this,  however,
igure 6. Table shows interpretation according to the raised b
ignal and ADC on DWI (modiﬁed from Khoo et al.).
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nd  far  less  black  and  white.  The  actual  question  is  to
etermine  the  most  discriminating  threshold  value  because
f  overlap  in  ADC  values  between  benign  and  malignant
umors.
A  large  number  of  studies  have  yielded  conﬂicting  results
nd  have  found  different  cut  off  ADC  values  although
he  most  discriminating  ADC  value  appears  to  be  near
 ×  10—3 mm2·s−1.
According  to  Neubauer  et  al.,  a  mean  ADC
alue  ≤  1.03  ×  10−3 mm2·s−1 is  a  strong  indicator  of  a
rimary  malignant  tumor.  Ginat  et  al.  combined  this  mean
DC  value  with  a value  of  1.65  ×  10−3 mm2·s−1 for  a  benign
umor  [5,6].
The  major  difﬁculty  is  that  all  of  these  studies  are  dif-
cult  to  compare  because  of  a variations  in  histological
ypes  of  tumors,  differences  in  DWI  techniques  (equipment,
 values  and  DWI  sequences).  All  authors,  however,  agree
pon  the  fact  that  an  aggressive  tumor  has  a  very  low  ADC
Figs.  7  and  8).
In  addition  to  the  problem  of  the  most  discriminating  cut
ff  value  to  differentiate  between  benign  and  malignant
umors,  there  is  a  problem  distinguishing  between  tumors
long  the  same  histological  continuum.  Ginat  et  al.  found
n  overlap  in  ADC  values  between  an  extensive  chondroma
s  compared  to  a  low  grade  chondrosarcoma.  DWI  also  fails
n  eosinic  granulomas  because  of  their  high  cell  density  [6].
One  should  note  that  at  present  no  cut  off  value
has  been  validated  as  a  consensus  in  the  literature
in  order  to  distinguish  between  benign  and  malignant
tumor  and  that  DWI  of  any  primary  bone  tumor  should
be  interpreted  according  to  its  matrix  and  therefore
its  appearance  on  standard  MR  imaging  (T1-  and  T2-
weighted  MR  images  and  T1-weighted  after  gadolinium
administration).
After  attempting  to  characterize  a  tissue,  DWI  was  then
sed  for  monitoring  bone  tumors  on  treatment.
The  assessment  of  the  response  of  osteosarcoma  and
wing’s  sarcoma  to  chemotherapy  appears  to  conform  well,
ith  an  increasing  ADC  from  baseline  when  the  tumor  shows
ood  response  to  therapy  [7,8].  Its  use  in  the  follow-up  of
reated  tumors  appears  to  be  less  problematic  than  in  the
nitial  characterization  of  the  lesion  as  variations  in  ADC
alue  are  interpreted  by  comparison  with  the  initial  ADC
alue  [9]  (Fig.  9).
Khoo  et  al.  found  the  minimum  ADC  to  be  useful  in  follow
p,  the  differences  being  more  signiﬁcant  than  for  the  mean
DC  value,  particularly  in  osteosarcomas  [3].  They  also  high-
ighted  the  problem  of  interpreting  DWI  if  partial  or  total
ecrosis  was  present  with  the  appearance  of  ‘‘T2  shine
hrough’’  effect  which  can  be  a  major  diagnostic  pitfall  [4].
Take  home  point
The  increase  in  ADC  value  from  pre-treatment
baseline  correlates  with  a  good  response  to  treatment.
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Figure 7. Sixty-six-year-old female with a past history of ovarian cancer. Found to have an osteolytic lesion in her right iliac wing (arrows).
A CT-guided biopsy with histological examination revealed a plasmacytoma of the right iliac wing (arrows). Note the b1000 hyper-intensity
and reduced ADC (a). Corresponding CT (b).
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Following  the  same  principle  as  for  bone  tumors,  DWI  in  soft
tissue  tumors  has  been  assessed  in  order  to  distinguish  malig-
nant  from  benign  lesion,  with  a  signiﬁcantly  lower  ADC  in
malignant  lesions.
Interpretation  of  the  diffusion-weighted  image  must  take
account  of  the  composition  and  heterogeneity  of  the  tumor
(cartilage,  myxoid  matrix,  ﬁbrosis  fat,  blood).  The  ADC  is
higher  in  cartilaginous  and  cystic  myxoid  tissue.  DWI  must
therefore  be  interpreted  along  with  conventional  anatom-
ical  images  (T1-  and  T2-weighted  and  T1-weighted  after
gadolinium  administration)  (Figs.  10,  11,  12).
According  to  Nagata  et  al.,  DWI  helps  discriminate
between  myxoid  and  non-myxoid  tumor  and  between  benign
non-myxoid  and  malignant  non-myxoid  tumor  [10].  Gen-
ovese  et  al.  showed  that  benign  myxoid  tumors  can  also  be
distinguished  from  malignant  myxoid  ones  whereas  Maeda
et  al.  did  not  reach  similar  conclusions  [11,12].
Oka  et  al.  reported  that  diffusion  helped  distinguishing
desmoid  tumor  from  malignant  tumor  and  according  to  both
Drapé  and  Oka  et  al.,  DWI  is  also  useful  to  differentiate  sar-
comas  with  internal  bleeding  from  space-occupying  chronic
hematomas  [4,13].
As  for  bone  tumors,  several  studies  have  reported  dif-
ferent  ‘‘cut  off’’  ADC  values.  Razek  et  al.  deﬁned  a  cut
off  ADC  value  of  1.34  mm2·s−1 in  tumors  of  the  extremity
with  accuracy,  sensitivity  and  speciﬁcity  of  91%,  94%  and
88%,  respectively  for  discriminating  between  benign  and
poorly  differentiated  tumors  [14].  Nagata  et  al.  deﬁned  a
cut  off  of  1.35  mm2·s−1 in  aggressive  tumors  compared  with
t
I
m
a.97  mm2·s−1 in  benign  lesions  and  Van  Rijswijk  et  al.  found
DC  values  of  1.08  mm2·s−1 and  1.71  mm2·s−1 [15,16].
DWI  appears  to  perform  well  in  the  assessment  of
esponse  to  chemotherapy  of  soft  tissue  sarcomas  with  an
ncreasing  ADC  from  baseline  in  good  responses  [17,18].
Take  home  point
At  present  no  cut  off  point  has  been  established
in  the  literature  as  a  consensus  to  distinguish  a
benign  from  a  malignant  tumor  and  any  soft  tissue
tumor  must  be  interpreted  alongside  its  appearance  on
conventional  images  and  its  matrix.
ncologic staging assessment
everal  studies  have  evaluated  the  capabilities  of  DWI  for
he  detection  of  secondary  lesions  from  solid  cancers  and
ymphomas  [19]. DWI  provides  complete  mapping  of  tissues
nd  therefore  local,  regional  and  remote  ‘‘staging’’  of  the
isease.
Whole  body  MR  imaging  with  DWI  images  can  be  used
or  full  screening  (bone  and  lymph  nodes)  and  is  superior
o  other  imaging  techniques  (i.e.,  scintigraphy,  computed
omography  (CT)  or  PET-CT)  in  prostatic  cancer  (Fig.  13).
t  is  also  effective  for  the  follow-up  of  patients  after  treat-
ent.  In  general,  there  is  a  gradual  increase  in  the  ADC  value
nd  a  drop  in  signal  intensity  due  to  cellular  apoptosis  in
332  
Figure 8. Fourteen-year-old male was found incidentally in a
radiological assessment of right hip pain to have a cystic lesion in
the right iliac wing suggestive of an aneurysmal cyst (arrow). Note
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Take  home  pointhe typical appearance on b1000 T2-weighted hyper-intensity with
o reduction in diffusion.
umors  that  respond  favorably  to  treatment,  although  these
hanges  are  often  slow  and  heterogeneous  [20,21].
DWI  has  been  found  to  be  more  sensitive  than  scintig-
aphy  and  PET-CT  in  children  and  young  adults  for  the
valuation  of  bone  metastases,  Ewing’s  sarcoma  or  osteosar-
oma  despite  a  number  of  false  positive  ﬁndings  due  to
yperplastic  bone  marrow  as  a  result  of  the  use  of  granu-
ocyte  growth  factors  [3]  (Fig.  14).
Myeloma  is  a  malignant  condition,  which  has  been  widely
tudied  both  for  detection  and  follow-up  (Fig.  15).  Despite
nconsistent  results  particularly  in  terms  of  reproducibility,
hree  different  studies  have  demonstrated  that  DWI  has
n  undisputed  role  in  monitoring  response  to  treatment
22—24].  However  Messiou  et  al.  found  that  the  combination
f  T1-weighted  and  STIR  images  is  still  superior  to  DWI  [25].B.  Dallaudière  et  al.
Lin  et  al.  reported  that  DWI  is  a  useful  technique  to  depict
iffuse  bone  marrow  involvement  in  lymphomas,  as  it  shows
 drop  in  ADC  value  [26,27].
Take  home  point
‘‘Whole  body  DWI’’  used  in  combination  with
standard  MR  images  provide  complete  mapping  in  the
initial  assessment  of  the  disease  and  are  useful  for  the
follow-up  of  the  disease  after  treatment.
nﬂammatory rheumatic diseases
eronegative spondyloarthropathies
n  the  ﬁeld  of  seronegative  spondyloarthropathy,  DWI  has
nferior  diagnostic  capabilities  than  STIR  MR  imaging  but  is
quivalent  to  contrast-enhanced  MR  imaging  to  detect  the
esion  [28].
In  order  to  distinguish  between  rheumatic  and  degenera-
ive  disease,  Bozeyik  et  al.  and  Dallaudière  et  al.  showed
ubstantial  differences  in  ADC  values  (greater  ADC  value
n  rheumatic  disease)  between  sacro-iliac  and  spinal  dis-
ase,  with  a  cut  off  value  around  0.57  mm2·s−1.  These  results
hould  be  conﬁrmed  by  larger  studies  [29,30]  (Fig.  16).
Many  studies  have  shown  that  DWI  is  a  useful  technique
or  the  follow-up  after  treatment  because  the  ADC  drops  in
atients  respond  well  [31].
heumatoid arthritis
he  use  of  DWI  in  rheumatoid  arthritis  has  received  little
ttention  in  the  literature  [32].  Two  studies  have  stud-
ed  inﬂammation  of  the  synovial  C1  C2  pannus  [33,34].
hey  both  concluded  that  DWI  has  little  utility  in  everyday
ractice  [33,34].
Take  home  point
ADC  may  be  of  diagnostic  assistance  if  difﬁculties
arise  in  distinguishing  between  degenerative  and
rheumatic  disease.  ADC  value  is  generally  higher  in
inﬂammatory  disease.
nfectious disease
iffusivity  is  restricted  in  osteomyelitis,  spondylodiscitis  or
n  abscesses  containing  a  viscous  liquid,  which  is  protein
ich.  The  large  increase  in  diffusivity  and  drop  in  ADC  value
herefore  make  it  difﬁcult  to  distinguish  between  malignant
nd  infectious  lesions  (sensitivity  and  speciﬁcity  around  60%)
Fig.  17)  [3].
DWI  appears  to  be  useful  to  distinguish  degenerative  dis-
ase  from  infection,  the  ADC  value  being  higher  in  bone
arrow  infection  (Fig.  18) [35].Unlike  cerebral  imaging,  diffusion-weighted  imaging
does  not  appear  to  be  useful  in  soft  tissue  abscesses.
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Figure 9. (a) ﬁfty-one-year-old male followed up for lung adenocarcinoma treated by right upper lobectomy. The patient developed left
sciatica due to a left sacral secondary site. Note the relative restriction of diffusion with a slightly reduced ADC (arrows). (b) same patient
after radiotherapy and then surgery because of persistent pain. Note the b1000 hyper-intensity with no restriction of diffusion indicating
early post-surgical changes (sero-sanguinous liquid) (arrows).
Degenerative disease
DWI  imaging  has  been  used  to  study  bone  in  order  to  deﬁne
normal  values  of  around  0.45  mm2·s−1 (Fig.  19)  [30,36]. DWI
ﬁndings  correlate  with  the  ﬁndings  observed  on  T1-weighted
and  STIR  MR  images  and  with  bone  densitometry  [37].
Grifﬁth  et  al.  found  that  quantiﬁcation  of  osteoporosis
correlated  with  microperfusion  abnormalities  but  not  with
the  diffusion  itself  [38].
Some  authors  tried  to  quantify  DWI  of  disc  degeneration.
They  found  a  reduced  ADC  value  when  active  disease  was
present  and  therefore  disc  dehydration,  although  this  is  not
used  in  daily  practice  [39].  However  the  ADC  value  of  bone
marrow  appears  to  be  increased  in  degenerative  disease
compared  to  normal  cannalicular  bone  [30]  (Fig.  20).
Figure 10. Forty-year-old male with pain in the left superﬁcial
ﬁbular nerve territory with a trigger area. MRI reveals a schwanoma
of the leg along the tract of the nerve. Note the central restriction of
diffusion (arrows). The imaging diagnosis is made from conventional
image sequences.
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s  part  of  the  investigation,  DWI  appears  to  be  useful  in
rauma  and  for  the  post-operative  examination  of  the  tibial
unnel  after  anterior  cruciate  ligament  reconstruction.  ADC
alls  compared  to  post-gadolinium  enhanced  MRI  (as  does
nhancement)  if  the  response  to  surgery  is  good  although
his  is  still  only  a  single  feasibility  study  [40,41].
Take  home  point
DWI  is  currently  only  being  assessed  in  degenerative
and  traumatic  disease.
A benign  vertebral  collapse  is  due  to  microfractures  with
dema.  In  malignant  collapse  fracture,  fracture  is  combined
ith  involvement  by  malignant  cells  (Fig.  21).  Qualita-
ively,  abnormal  persisting  hyper-intensity  on  DWI  after  6
onths  is  suggestive  of  a  pathological  collapse  fracture
3,42]. Quantitatively,  ADC  value  is  signiﬁcantly  lower  in  a
alignant  collapse  fracture  with  a  sensitivity  of  100%  and
peciﬁcity  93%.  Furthermore,  DWI  is  similar  to  T1-weighted,
2-weighted  and  STIR  MR  imaging  in  terms  of  lesion  char-
cterization  (Fig.  22) [42].  No  deﬁnite  cut  off  ADC  value
owever  has  been  found;  the  ADC  value  strongly  depends
n  the  extent  of  tumor  inﬁltration  in  the  vertebra,  which
ay  vary  greatly  according  to  the  stage  of  the  disease
43,44].
In a recent  series,  Pozzi  et  al.  also  found  similar  results,
hereas  Geith  et  al.  found  that  DWI  was  not  speciﬁc  enough
o  characterize  a  collapse  fracture  [45,46].  These  inconsis-
ent  results  should  be  conﬁrmed  by  larger  prospective  trials.
All  authors  agree  that  DWI  must  be  interpreted  with
he  knowledge  of  the  type  of  lesion  (sclerotic,  lytic  or
ixed,  metastases,  etc.),  the  treatment  (radiotherapy,
hemotherapy,  bisphosphonates)  and  knowledge  of  the  pos-
ible  T2-weighted  ‘‘shine  through’’  effect,  in  order  to  avoid
nterpretation  errors.
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Figure 11. Thirty-eight-year-old woman with sub-acute hypodermic hematoma of the leg due to direct injury. Note the restriction of
diffusion with a reduced ADC (arrows).
Figure 12. Fifty-three-year-old man with superﬁcial neck lipoma. The lesion shows hyper-intensity on T1- and T2-weighted MR images
(arrows) with a very low diffusion and ADC values (arrow heads).
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Figure 13. Seventy-two-year-old man with prostatic adenocarcinoma. Staging is performed using whole body MRI. Note the restriction of
diffusion from a right iliac metastasis (arrow).
Figure 14. Stimulated bone marrow in a ﬁfty-ﬁve-year-old male patient treated for lung malignancy. Note the DWI hypo-intensity (in the
negative: ‘‘PET-like’’or ‘‘scinti-like’’) and the appearance of the bone marrow on T1-weighted imaging.
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Figure 15. Multiple myeloma with diffuse inﬁltration of the bone marrow. Note the DWI hypo-intensity (in the negative: ‘‘PET-like’’ or
‘‘scinti-like’’) with a T1-weighted hypo-intensity and a slight STIR hyper-intensity in a ﬁfty-six-year-old woman (arrows).
Figure 16. ADC mapping, 35-year-old male with romanus
spondylitis (arrow).Figure 17. Eighty-two-year-old male patient with a left buttock
abscess. Note the restriction of diffusion with a moderately reduced
ADC associated with a thick purulent liquid component (arrows).
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Figure 18. Sixty-eight-year-old male with pyogenic L4-L5 spondylodiscitis. Restriction of diffusion from the disc is due to pus which is
rich in cells (arrows).
Figure 19. Thirty-three-year-old man with normal spine.
Figure 20. Sixty-ﬁve-year-old woman with Modic type 1 inﬂammatory changes in L4-L5 disc disease. Note the increase in diffusion
compared to healthy bone.
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Figure 21. Sixty-six-year-old woman with benign collapse fracture of T11 (white arrows). Note the absence of restriction of diffusion in
the vertebra (black arrow) and peri-vertebral soft tissues (arrow heads).
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Take  home  point
No  deﬁne  threshold  ADC  value  has  been  established
to  differentiate  between  benign  and  malignant  collapse
fracture  and  any  lesion  must  be  interpreted  according
to  the  clinical  situation  (time  between  the  collapse
and  pain)  whether  or  not  the  collapse  is  sclerotic  in
appearance  and  the  treatment  the  patient  is  receiving.
onclusion
WI  is  a  very  sensitive  technique  that  is  currently  used  in  a
arge  number  of  musculoskeletal  conditions.  DWI  is  a  valid
echnique  for  the  staging  of  some  solid  cancers.  In  terms  of
issue  characterization,  DWI  should  be  regarded  as  a  diag-
ostic  aid  and  DWI  features  must  always  be  compared  to
he  appearances  of  the  lesion  on  conventional  MR  imaging
articularly  in  oncological  disease.  In  terms  of  follow-up  of
ancer  or  rheumatic  diseases,  the  change  in  ADC  values  may
rovide  additional  evidence  of  response  to  treatment,  which
s  more  reliable  than  the  initial  characterization  of  a  lesion
ut  still  must  be  interpreted  compared  to  the  initial  ADC
alue  of  the  lesion  and  knowledge  of  actual  treatments.
inally,  in  light  of  recent  studies  regarding  the  use  of  nor-
alized  ADC,  further  studies  should  be  done  to  determine  toting with malignant collapse fracture of L5. Note the b600 hyper-
hich  extent  the  use  of  normalized  ADC  might  help  improve
esion  characterization  in  musculoskeletal  diseases  [47,48].
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